Keyphrases
Indonesia
100%
Intensive Care Unit
57%
Jakarta
56%
Referral Hospital
37%
Pseudomonas Aeruginosa (P. aeruginosa)
35%
Klebsiella Pneumoniae (K. pneumoniae)
34%
Indonesian
31%
Carbapenem-susceptible
30%
Escherichia Coli
19%
Quantitative PCR
17%
COVID-19
15%
Gram-negative Bacteria
15%
Antimicrobial Resistance
15%
Complicated Intra-abdominal Infection (cIAI)
14%
Acid-fast Bacilli
13%
Polymerase Chain Reaction Assay
12%
Diphtheria
12%
Antibiotics
12%
Tuberculosis
12%
Epidemiology
12%
Antimicrobial Stewardship Program
12%
Asia
11%
Sputum
11%
Mycobacterium Tuberculosis (M. tb)
11%
Polymerase Chain Reaction
10%
Culture Method
10%
Consensus Conference
10%
Adaptation
10%
Brucella Abortus
9%
International Clone
9%
Infection Control Interventions
9%
Antibiotic Stewardship
9%
Antimicrobial Stewardship
9%
Asia-Pacific Countries
9%
Ziehl-Neelsen
9%
Toddlers
9%
Pandemi
9%
High Risk
9%
PcDNA3.1
9%
Risk Factors
9%
Expert Consensus
9%
Modul
9%
Procalcitonin
9%
Antibiotic Resistance Genes
9%
Acinetobacter Baumannii (A. baumannii)
9%
Blood Specimen
8%
Amikacin
7%
Baumannii
7%
Low-middle Income Countries
7%
Antimicrobial Susceptibility
7%
Medicine and Dentistry
Intensive Care Unit
46%
Carbapenem
38%
Patient Referral
37%
Pseudomonas aeruginosa
25%
Antibiotics
21%
Infection
17%
Acid Fast Bacterium
16%
Cohort Effect
15%
Abdominal Infection
14%
Systematic Review
14%
Sputum
13%
Antiinfective Agent
13%
Klebsiella pneumoniae
12%
Diagnosis
12%
Cross Sectional Study
12%
Antibiotic Resistance
11%
Prevalence
11%
Pathogen
11%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Infection Control
10%
Polymerase Chain Reaction
9%
COVID-19
9%
Real Time Polymerase Chain Reaction
9%
Extended Spectrum Beta Lactamase
9%
Gram-Negative Bacteria
9%
Mycobacterium Tuberculosis
8%
Polymerase Chain Reaction
8%
Lung Tuberculosis
8%
Procalcitonin
7%
Microscopy
7%
Sputum Culture
7%
Human Immunodeficiency Virus
7%
Cohort Analysis
7%
Fluorochrome
6%
Disease
6%
Drug Resistance
6%
Observational Study
6%
Quantitative Reverse Transcription Polymerase Chain Reaction
6%
Leukocyte
5%
In Vitro
5%
Prospective Cohort Study
5%
Serotype
5%
Health Care Cost
5%
Respiratory Tract Infection
5%
Ceftriaxone
5%
Nasopharyngeal Swab
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pseudomonas aeruginosa
23%
Antibiotics
23%
Infection
22%
Antibiotic Agent
18%
Infectious Agent
16%
Diphtheria
14%
Gram Negative Bacterium
14%
Prevalence
12%
Extended Spectrum Beta Lactamase
12%
Klebsiella pneumoniae
12%
Escherichia coli
11%
Antiinfective Agent
10%
Carbapenemase
9%
Abdominal Infection
9%
Antimicrobial Resistance
9%
Microorganism
9%
Meropenem
8%
Amikacin
8%
Antibiotic Resistance
8%
Levofloxacin
7%
Carbapenem
6%
Ceftriaxone
6%
Enterobacteriaceae
6%
Lung Tuberculosis
6%
Disease
6%
Mycobacterium Tuberculosis
5%
Prospective Cohort Study
5%
Sepsis
5%
SARS Coronavirus
5%
Cross-Sectional Study
5%
Corynebacterium
5%
Corynebacterium diphtheriae
5%
Acinetobacter Baumannii
5%